160 related articles for article (PubMed ID: 27774772)
21. Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.
Hirsch B; Endris V; Lassmann S; Weichert W; Pfarr N; Schirmacher P; Kovaleva V; Werner M; Bonzheim I; Fend F; Sperveslage J; Kaulich K; Zacher A; Reifenberger G; Köhrer K; Stepanow S; Lerke S; Mayr T; Aust DE; Baretton G; Weidner S; Jung A; Kirchner T; Hansmann ML; Burbat L; von der Wall E; Dietel M; Hummel M
Virchows Arch; 2018 Apr; 472(4):557-565. PubMed ID: 29374318
[TBL] [Abstract][Full Text] [Related]
22. Digital Sorting of Pure Cell Populations Enables Unambiguous Genetic Analysis of Heterogeneous Formalin-Fixed Paraffin-Embedded Tumors by Next Generation Sequencing.
Bolognesi C; Forcato C; Buson G; Fontana F; Mangano C; Doffini A; Sero V; Lanzellotto R; Signorini G; Calanca A; Sergio M; Romano R; Gianni S; Medoro G; Giorgini G; Morreau H; Barberis M; Corver WE; Manaresi N
Sci Rep; 2016 Feb; 6():20944. PubMed ID: 26864208
[TBL] [Abstract][Full Text] [Related]
23. Comparison of cytocentrifugation supernatant fluid and formalin-fixed paraffin-embedded tissue for targeted next-generation sequencing.
Janaki N; Harbhajanka A; Michael CW; Bomeisl P; Wasman J; Atchley M; Miskiewicz K; Alouani D; Sadri N
Cancer Cytopathol; 2019 May; 127(5):297-305. PubMed ID: 30933438
[TBL] [Abstract][Full Text] [Related]
24. Fusion of old and new: Employing touch imprint slides for next generation sequencing in solid tumors.
Aydin Mericoz C; Eren OC; Kulac I; Firat P
Diagn Cytopathol; 2024 May; 52(5):264-270. PubMed ID: 38339821
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas.
Khode R; Larsen DA; Culbreath BC; Parrish S; Walker KL; Sayage-Rabie L; Beissner RS; Rao A
Cancer Cytopathol; 2013 Jul; 121(7):361-9. PubMed ID: 23364874
[TBL] [Abstract][Full Text] [Related]
26. Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.
Bonfiglio S; Vanni I; Rossella V; Truini A; Lazarevic D; Dal Bello MG; Alama A; Mora M; Rijavec E; Genova C; Cittaro D; Grossi F; Coco S
BMC Cancer; 2016 Aug; 16(1):692. PubMed ID: 27578032
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of different massive parallel sequencing platforms for mutation profiling in formalin-fixed and paraffin-embedded samples].
Jiang RR; Wang YJ; Teng XD; Xiao L; Bu H; Ye F
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):591-596. PubMed ID: 30107663
[No Abstract] [Full Text] [Related]
28. Comprehensive mutation profiling by next-generation sequencing of effusion fluids from patients with high-grade serous ovarian carcinoma.
Shah RH; Scott SN; Brannon AR; Levine DA; Lin O; Berger MF
Cancer Cytopathol; 2015 May; 123(5):289-97. PubMed ID: 25655233
[TBL] [Abstract][Full Text] [Related]
29. Use of touch imprint cytology as a simple method to enrich tumor cells for molecular analysis.
Dogan S; Becker JC; Rekhtman N; Tang LH; Nafa K; Ladanyi M; Klimstra DS
Cancer Cytopathol; 2013 Jul; 121(7):354-60. PubMed ID: 23576371
[TBL] [Abstract][Full Text] [Related]
30. HaloPlex Targeted Resequencing for Mutation Detection in Clinical Formalin-Fixed, Paraffin-Embedded Tumor Samples.
Moens LN; Falk-Sörqvist E; Ljungström V; Mattsson J; Sundström M; La Fleur L; Mathot L; Micke P; Nilsson M; Botling J
J Mol Diagn; 2015 Nov; 17(6):729-39. PubMed ID: 26354930
[TBL] [Abstract][Full Text] [Related]
31. Confounding factors and diagnostic accuracy of imprint cytology.
Yadav GS; Donoghue M; Tauro DP; Bharani S; Kumar M; Yadav A
Acta Cytol; 2014; 58(1):53-9. PubMed ID: 24246359
[TBL] [Abstract][Full Text] [Related]
32. Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making.
De Paoli-Iseppi R; Johansson PA; Menzies AM; Dias KR; Pupo GM; Kakavand H; Wilmott JS; Mann GJ; Hayward NK; Dinger ME; Long GV; Scolyer RA
Pathology; 2016 Apr; 48(3):261-6. PubMed ID: 27020503
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue Samples.
Oh E; Choi YL; Kwon MJ; Kim RN; Kim YJ; Song JY; Jung KS; Shin YK
PLoS One; 2015; 10(12):e0144162. PubMed ID: 26641479
[TBL] [Abstract][Full Text] [Related]
34. Comparing touch imprint cytology, frozen section analysis, and cytokeratin immunostaining for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer.
Safai A; Razeghi A; Monabati A; Azarpira N; Talei A
Indian J Pathol Microbiol; 2012; 55(2):183-6. PubMed ID: 22771640
[TBL] [Abstract][Full Text] [Related]
35. Clinical next-generation sequencing in patients with non-small cell lung cancer.
Hagemann IS; Devarakonda S; Lockwood CM; Spencer DH; Guebert K; Bredemeyer AJ; Al-Kateb H; Nguyen TT; Duncavage EJ; Cottrell CE; Kulkarni S; Nagarajan R; Seibert K; Baggstrom M; Waqar SN; Pfeifer JD; Morgensztern D; Govindan R
Cancer; 2015 Feb; 121(4):631-9. PubMed ID: 25345567
[TBL] [Abstract][Full Text] [Related]
36. Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosis.
Maru Y; Tanaka N; Ohira M; Itami M; Hippo Y; Nagase H
Gynecol Oncol; 2017 Feb; 144(2):377-383. PubMed ID: 27939411
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of ascitic fluid cytology reflects genetic changes of malignancies of the ovary equivalent to surgically resected specimens.
Nozaki T; Sakamoto I; Kagami K; Amemiya K; Hirotsu Y; Mochizuki H; Omata M
Cancer Cytopathol; 2022 Aug; 130(8):640-649. PubMed ID: 35640087
[TBL] [Abstract][Full Text] [Related]
38. Impact of Pre-Analytical Variables on Cancer Targeted Gene Sequencing Efficiency.
Araujo LH; Timmers C; Shilo K; Zhao W; Zhang J; Yu L; Natarajan TG; Miller CJ; Yilmaz AS; Liu T; Amann J; Lapa E Silva JR; Ferreira CG; Carbone DP
PLoS One; 2015; 10(11):e0143092. PubMed ID: 26605948
[TBL] [Abstract][Full Text] [Related]
39. High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing.
Wagle N; Berger MF; Davis MJ; Blumenstiel B; Defelice M; Pochanard P; Ducar M; Van Hummelen P; Macconaill LE; Hahn WC; Meyerson M; Gabriel SB; Garraway LA
Cancer Discov; 2012 Jan; 2(1):82-93. PubMed ID: 22585170
[TBL] [Abstract][Full Text] [Related]
40. Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats.
Movassaghi M; Shabihkhani M; Hojat SA; Williams RR; Chung LK; Im K; Lucey GM; Wei B; Mareninov S; Wang MW; Ng DW; Tashjian RS; Magaki S; Perez-Rosendahl M; Yang I; Khanlou N; Vinters HV; Liau LM; Nghiemphu PL; Lai A; Cloughesy TF; Yong WH
Exp Mol Pathol; 2017 Aug; 103(1):87-93. PubMed ID: 28663030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
